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DOI 10.1016/j.cell.2011.08.005SUMMARY specific transcription factors and components of the multi-Deciphering the molecular basis of pluripotency is
fundamental to our understanding of development
and embryonic stem cell function. Here, we report
that TAF3, a TBP-associated core promoter factor,
is highly enriched in ES cells. In this context, TAF3
is required for endoderm lineage differentiation and
prevents premature specification of neuroectoderm
and mesoderm. In addition to its role in the core
promoter recognition complex TFIID, genome-wide
binding studies reveal that TAF3 localizes to a subset
of chromosomal regions bound by CTCF/cohesin
that are selectively associated with genes upregu-
lated by TAF3. Notably, CTCF directly recruits TAF3
to promoter distal sites and TAF3-dependent DNA
looping is observed between the promoter distal
sites and core promoters occupied by TAF3/CTCF/
cohesin. Together, our findings support a new role
of TAF3 in mediating long-range chromatin regula-
tory interactions that safeguard the finely-balanced
transcriptional programs underlying pluripotency.
INTRODUCTION
A hallmark of embryonic stem (ES) cells is their ability to generate
all somatic cell types that make up an animal (Bradley et al.,
1984). This differentiation potential of ES cells, or pluripotency,
is thought to hold great promise for the future of regenerative
medicine (Daley and Scadden, 2008). To fully develop the
emerging field of stem cell-based therapies, a deeper under-
standing of the molecular basis underlying ES cell pluripotency
and the mechanisms controlling cellular differentiation is
required. The regulatory pathways that govern ES cell self-
renewal and pluripotency include a subset of sequence-specific
DNA binding transcription factors (Oct4, Nanog, Sox2, Klf4, etc.;
Jaenisch and Young, 2008) consistent with the importance of
enhancer- and promoter- binding transcription factors in regu-
lating lineage specification during early embryogenesis (Arnold
and Robertson, 2009; Tam and Loebel, 2007).
In eukaryotic cells, a key feature of transcriptional regulation is
the complex and still poorly understood interplay between gene-720 Cell 146, 720–731, September 2, 2011 ª2011 Elsevier Inc.subunit core promoter recognition machinery (Naar et al.,
2001). Until recently, it was believed that proper gene and cell-
type specific transcriptional read-outs were exclusively
controlled by combinatorial arrays of classic sequence-specific
enhancer binding activators and repressors (Farnham, 2009;
Tjian and Maniatis, 1994). By contrast, the so called general or
ubiquitous transcription machinery responsible for core
promoter recognition was thought to serve mainly as a passive
integrator or processor of upstream regulatory signals. How-
ever, an increasing number of cell type- and tissue-specific
components of the core promoter recognition apparatus have
been identified in metazoan organisms and shown to play
a role in directing and regulating programs of transcription
during the development of specific cell types (Goodrich and
Tjian, 2010).
In this report, we focus on the TATA binding protein associated
factor 3, TAF3, which was originally identified as a subunit of the
TFIID complex in HeLa cells (Gangloff et al., 2001). It was later
found that, while other TFIID subunits are destroyed during myo-
genesis, TAF3 is selectively retained inmyotubes in a specialized
complex with TBP-related factor 3, TRF3 (Deato and Tjian,
2007). A similar TRF3/TAF3 complex functions during Zebrafish
hematopoiesis (Hart et al., 2009). A recent study implicates
subnuclear localization of TAF3 as another potential mechanism
to regulate transcription during myogenesis (Yao et al., 2011).
Intriguingly, TAF3 also recognizes trimethylated histone H3
lysine 4 (H3K4me3) (Vermeulen et al., 2007), which is associated
not only with actively transcribed genes but also with silent
developmental genes that are poised for activation upon ES
cell differentiation (Bernstein et al., 2006; Mikkelsen et al.,
2007). Thus, these studies establish that TAF3, either as a subunit
of TFIID or in association with other potential partners (e.g.,
TRF3) may regulate transcription by targeting cell-type-specific
complexes to core promoters including those that are marked
by H3K4me3. Here we report a novel mode of TAF3 action:
TAF3 binds the architectural protein CTCF via its vertebrate-
specific domain to mediate regulatory interactions between
distal CTCF/cohesin bound regions and proximal promoters.
Remarkably, we show that this TAF3 activity is critical for early
lineage segregation during stem cell differentiation. Thus, our
findings unmask new mechanisms that directly link dynamic
organization of chromatin structure and transcriptional control
of stem cell plasticity.
Figure 1. High Levels of TAF3 in ES Cells
(A) Western blots to examine TAF3 levels in different cell types and tissues.
(B) TAF3 is selectively reduced upon ES cell differentiation (EB day 1, 2, 4, 6, 8,
and 10). For related data, see also Figure S1.RESULTS
Highly Elevated Levels of TAF3 in ES Cells
To explore the possibility that TAF3 and/or TRF3/TAF3
complexes may be utilized in different developmental pathways,
we analyzed TAF3 protein levels across different tissue types and
cell lines by western blot. Unexpectedly, we found the highest
TAF3 protein levels (103 relative to C2C12’s) in mouse ES cells
(Figure 1A). Evenmore interestingly, whenwe induced ES cells to
form embryoid bodies (EBs), TAF3 protein levels became selec-
tively reduced while the prototypic subunits (TAF4a and TBP) of
TFIID remained mostly unchanged (Figure 1B). We next asked
whether high levels of TAF3 in ES cells are accompanied by
a concomitant enrichment of TRF3. Surprisingly, Trf3 mRNA
was not detectable in either ES cells or EBs (Figure S1A available
online). Consistent with this, we found that in ES cell nuclear
extracts, TAF3 protein migrated at a molecular weight > 1MD
(Figure S1B), while the TAF3/TRF3 complex from myoblast/my-
otubes migrates as a native species of180kd (Deato and Tjian,
2007). These findings indicate that although TAF3 is highly ex-
pressed in ES cells, one of its potential partners (TRF3) is absent,
suggesting another distinct functional mode for TAF3.High Levels of TAF3 Are Not Required for ES Cell
Proliferation and Self-Renewal
Experiments with two independent lentivirus-mediated shRNAs,
which specifically and stably knocked down (K/D) TAF3 in ES
cells (Figure 2A), reveal that TAF3 depletion did not affect the
expression of the known ES cell self-renewal genes, Oct4 and
Nanog (Figures 2A, 2B, 2F, and 2G). TAF3 K/D cells were also
able to form alkaline phosphatase positive colonies as efficiently
as control ES cells (Figure 2C) and the percentage of SSEA1+
Oct4+ cells upon efficient TAF3 K/D remained largely unaltered
(Figure 2D and S2A). Furthermore, no correlation between
TAF3+ and Nanog+ cells was detected by immunofluorescencestaining of individual ES cells (Figures 2G and 2H). Another
important hallmark of ES cells and their self-renewal properties
is their elevated proliferative rates compared to somatic cells,
which results in a higher proportion of S phase ES cells in the
population. To gain a semiquantitative assessment of whether
TAF3 K/D impedes ES cell proliferation, we pulse-labeled S
phase control and TAF3 K/D cells with 5-ethynyl-20-deoxyuridine
(EdU) and analyzed changes in the cell cycle by flow cytometry.
We observed only modest reductions (5%–8%) in the S phase
population of TAF3 K/D cells. Indeed, >70% of TAF3 K/D cells
were found in S phase and no significant G1 or G2/M cell-cycle
arrest was detected (Figure 2E and Figure S2B). These results
indicate that ES cell proliferation is likely not critically dependent
on high levels of TAF3. Importantly, the protein levels of canon-
ical TFIID subunits (TAF1, TAF4, and TBP) remained stable after
TAF3 depletion (Figure 2A), suggesting that the integrity of TFIID
also does not rely on high levels of TAF3 in ES cells. The striking
absence of any notable self-renewal or proliferation phenotypes
in TAF3 K/D cells suggests that TAF3 may selectively contribute
to the proper transcription of a subset of genes involved in pluri-
potency of ES cells.
TAF3 Is a Regulator of Pluripotency
To test whether the high levels of TAF3 in ES cells are required for
pluripotency, we induced stable pools of TAF3 K/D and control
ES cells to form EBs. Control ES cells formed EBs with the ex-
pected heterogeneous cell lineages (Figure 3D). By contrast,
TAF3K/DEBsappearedabnormal and lackedwell-definedstruc-
tures (e.g., multiple cell layers, cavitations in the inner cells), sug-
gesting that one or more differentiation programsmay have been
compromised. We next used qRT-PCR to survey the expression
levels of lineage-specific markers in both control and TAF3 K/D
EBs (Figures 3A–3C). As expected, the expression of lineage-
specific markers was generally upregulated in control EBs.
However, in TAF3 K/D EBs the expression of primitive endoderm
markers (Gata6 and Gata4) was largely abolished, while meso-
derm and ectoderm markers (T, Pax3, nestin, and Fgf5) were
induced at earlier time points and expressed at higher levels.
To better understand the TAF3 K/D EB phenotype, we stained
control and TAF3 K/D EBs with lineage-specific antibodies. As
expected, GATA4 stained the outer layer and some internal cells
in control EBs, while no significant GATA4 signal was detected in
TAF3 K/D EBs (Figure 3E). Likewise, Afp, a late endoderm
marker, stained control EBs but not TAF3 K/D EBs (Figure 3F
and Figure S3C). These results are consistent with our qRT-
PCR results that indicated impaired endoderm development in
TAF3 K/D EBs. To address ectoderm differentiation, we used
an ES cell line (46C) with GFP knocked into the Sox1 locus
(Ying et al., 2003) to analyze control and TAF3 K/D samples (Fig-
ure 3G). At EB day 8, more than half of the TAF3 K/D EBs (21/30
for shRNA A and 16/30 for shRNA B) developed strong internal
GFP signals. In contrast, none of the control EBs (0/30) were
GFP positive. In light of the finding that early neuroectoderm
markers (Sox1 and nestin) became dramatically upregulated in
TAF3 K/D EBs, we plated control and TAF3 K/D EBs (day 4)
onto laminin coated slides.We observed extensive axon network
out-growth from TAF3 K/D EBs but not from control EBs (Fig-
ure 3H and Figures S3D and S3E). Apparently, even withoutCell 146, 720–731, September 2, 2011 ª2011 Elsevier Inc. 721
Figure 2. TAF3 Depletion Does Not Affect ES Cell Self-Renewal Genes
(A) Western blots to analyze the protein levels of Taf1, Taf3, Taf4, Tbp, Nanog and Oct4 in control and TAF3 K/D cells (D3, P2 postinfection).
(B) qRT-PCR to measure the mRNA levels of Taf3, Nanog and Oct4 in control and TAF3 K/D cells (D3, P2 postinfection).
(C) Alkaline phosphatase staining of control and TAF3 K/D cell colonies (R1, P4 postinfection) on feeder cells.
(D) Percentages of SSEA1+Oct4+ cells in wild-type, control and TAF3 K/D cell populations (D3, P6 postinfection).
(E) Percentages of S phase cells in wild-type, control and TAF3 K/D cell populations (D3, analyzed for 6 passages postinfection).
(F–G) Confocal fluorescence images of control and TAF3 K/D cells (R1, Passage 4 postinfection) costained with antibodies against TAF3 and Oct4 (F) or TAF3 and
Nanog (G). Nuclei were counterstained with DAPI.
(H) Single cell expression correlation analysis of TAF3 and Nanog in shRNA A treated cells (R1, P4 postinfection). Gray values along a random chosen path in
DAPI, TAF3 (shRNA A) and Nanog channels of (G) were plotted in the diagram. Scale bars represent 150 mm in (C), and in others, 50 mm. See also Figure S2.chemical induction, TAF3 K/D diverted a significant proportion of
ES cells to differentiate into neurons. We further confirmed the
TAF3 K/D phenotype of EBs by western blot analysis (Fig-
ure S3B). In conclusion, these data strongly suggest that high
levels of TAF3 in ES cells may be essential for proper cell lineage
specification during differentiation.
To test whether TAF3 expression is lineage-specific in EBs, we
costained EBs (day10) with anti-GATA4 and anti-TAF3 anti-
bodies. Whereas GATA4 strongly stained the outer layer cells
of EBs, TAF3 staining (though at low levels compared to ES cells;
Figure 1B) was quite homogenous and apparently not lineage-
specific (Figure 3I and 3J). Together, these results suggest a crit-
ical role for TAF3 in directing cell fate choices at very early stages
during ES cell differentiation.
TAF3 Regulates Endoderm-Specific Gene Expression
Programs
To identify the full range of genes regulated by TAF3 in ES cells,
we combined shRNA-based TAF3 K/D with mRNA-seq. We also722 Cell 146, 720–731, September 2, 2011 ª2011 Elsevier Inc.measured expression changes at EB day 3 and EB day 6 to char-
acterize the temporal dynamics and downstream consequences
of TAF3 depletion. On average we detected 2119 genes (10%
of those assayed) upregulated at each time point (Table S1) and
by EB day 6 theseweremassively biased toward neuroectoderm
associated Gene Ontology categories such as ‘‘nervous system
development’’ (p < 1E-20), ‘‘axon guidance’’ (p < 1E-9) and
‘‘synaptic transmission’’ (p < 1E-4; Table S2). Notably however,
this bias was evident even in undifferentiated TAF3 K/D cells
(‘‘nervous system development,’’ p < 1E-7) and could be traced
to early neuroectoderm (Sox1, Pax6), neural crest (Zic1, Zic2)
and neuronal stem cell markers (Nes; Figure 4A, column 1).
Subsequently, by EB day 3 and EB day 6, many markers of
more differentiated cell types such as neurons (Tubb3, Grm2,
Kcnc1, Foxp2), glia (Fabp7, Gli1) and oligodendrocyte (Olig3)
were significantly upregulated.
In contrast to neuroectodermal genes, endoderm markers
were uniformly downregulated by TAF3 K/D (Figure 4A, column
2). Essentially all showed defects by EB day 3, suggesting that
Figure 3. TAF3 Regulates ES Cell Pluripo-
tency
(A–C) qRT-PCR to measure the expression of
lineage-specific markers in control and TAF3 K/D
samples.
(D) H&E staining of EB sections from control and
TAF3 K/D EBs (day 10).
(E and F) Confocal fluorescence images of control
and TAF3 K/D EBs (day 10) stained with antibody
against GATA4 (E) or Afp (F).
(G) Live-cell fluorescence images of control and
TAF3 K/D EBs (day 8, 46C). (H) Confocal fluores-
cence images of control and TAF3 K/D EBs
stained with antibody against Tubb3. EBs (day 4)
were cultured on Laminin coated slides for 6
additional days.
(I) Confocal fluorescence images of control and
TAF3 K/D EBs (day 10) costained with antibodies
against TAF3 and GATA4.
(J) Gray values along a path from outside to inside
of the EB (nontarget) in DAPI, TAF3 and GATA4
channels of (I) were plotted in the diagram.
Scale bars represent 50 mm. For additional data,
see Figure S3.TAF3 depletion rapidly limits endoderm differentiation potential.
It was surprising then that Gene Ontology analysis failed to iden-
tify a strong unifying theme for downregulated genes, though
consistent with our cell-cycle assays (Figure 2E), we detected
modest downregulation of some housekeeping genes (Table
S2). Reasoning that this was due to the smaller number of signif-
icantly downregulated genes at each time point (1165 versus
2119 on average) and the comparative lack of information
regarding endoderm development (Grapin-Botton and Con-
stam, 2007), we directly compared our data to tissue- and
stage-specific SAGE libraries (Khattra et al., 2007). Briefly, we
ordered genes by the change in expression following TAF3 K/D
and assessed the numbers of genes found exclusively in either
of two SAGE libraries in windows along this axis. Our measure
of tissue bias (Figure 4B, red line) showed that upregulated
genes were biased toward the brain library while downregulated
genes were biased toward the endoderm library. By contrast,
tissue bias computed using random orderings of genes (gray
line) or random pairings of libraries (Figure S4A) showed no rela-
tionship to the underlying gene expression (black points). There-
fore, our data demonstrate that TAF3 is required both for repres-
sion of a neural expression program and for activation of many
endodermal genes.
During early embryogenesis, the correct execution of
patterning gene expression programs is essential for proper
cell migration and fate allocation (Arnold and Robertson, 2009).
In this regard, our genome-wide expression data also revealed
an unexpected overlap between upregulated genes and pro-
cesses related toWnt-b-catenin signaling such as ‘‘Wnt receptorCell 146, 720–731, Ssignaling pathway’’ (p < 1E-6; Table S2).
In addition to several members of the
core b-catenin pathway, at least 8 Wnts
were strongly affected as were the
majority of frizzled and sFRP genes (Fig-ure 4A, columns 3–5). We also observed upregulation of several
members of the nodal pathway (Nodal, Lefty1, Cer1; Figure 4A,
column 3). In this case the pathway is too small to achieve statis-
tical significance in genome-wide tests but the observation may
nevertheless be biologically significant as discussed below. In
contrast to the number of changes in the nodal pathway, only
one subunit each of the Mediator and TFIID complexes (dis-
counting TAF3 itself) displayed strong TAF3 K/D defects (Fig-
ure 4A, columns 6 and 7).
TAF3 Is Required for Endoderm Specification
in a Teratoma Model
As a more stringent pluripotency test, a teratoma model was
used to evaluate the in vivo differentiation capacity of TAF3
K/D cells. Control teratomas contained the expected tissue
types from all three germ layers (Figure S5A; panels a–i). In
contrast, teratomas generated from TAF3 K/D cells were
devoid of endoderm tissues and were mainly composed of
muscle (mesoderm), neural tissue and epidermis (ectoderm)
(Figure S5A; panels j–o). To gain a quantitative view of how
TAF3 K/D affected teratoma formation, qRT-PCR and western
blots were used to assess the expression of different tissue-
specific genes (Figures S5B and S5C). The expression of
pan-endoderm markers was significantly downregulated
(10- to 20-fold) while the expression of skeletal muscle-specific
genes was dramatically upregulated (5- to 10-fold) in TAF3
K/D teratomas. In contrast to the results of the in vitro EB
formation experiments, the expression of neuronal markers
was reduced (2 fold) in TAF3 K/D samples. Despite this,eptember 2, 2011 ª2011 Elsevier Inc. 723
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Figure 4. TAF3 Represses Neuroectodermal Genes and Is Required for Expression of Endodermal Genes
(A) Difference in expression (log2[anti-TAF3 shRNA A/nontarget shRNA]) and statistical significance between TAF3 depleted ES cells and controls for selected
genes at three time points, ES Cell, EB day 3 and EB day 6.
(B) Tissue bias (red line; Experimental Procedures) calculated between definitive endoderm (E8.0; SM143) and whole brain (E12.5; SM108) SAGE libraries plotted
on the difference in expression (defined as in [A]; black points) between TAF3 K/D cells and controls. Tissue bias recalculated using randomized gene expression
data was plotted in gray.
(C) Overlaps between genes that were differentially expressed in TAF3 K/D EBs at day 6 (EB6) and genes that were differentially expressed in Sox17 over-
expressing human embryonic stem cells. p values for each intersection were calculated assuming a hypergeometric distribution and a total ortholog count of
14,400. Values significant at the 5% level were plotted in red. For related data, see also Table S1 and Table S2, as well as Figure S4.differentiation toward neural lineages was largely unimpeded
(Figure S5A; panels k and n). Although the results from the
teratoma assay deviate somewhat from the results we
observed during EB formation, we speculate that either the
dramatic upregulation of mesoderm differentiation ultimately
overwhelms the neuroectoderm program during the long
periods of teratoma formation in vivo (6 weeks versus
6–10 days in EBs) or that environmental and physiological
cues in the teratoma niche reset the differentiation bias of
TAF3 K/D cells.
Supporting the notion that residual TAF3 is sufficient to form
a complex with TRF3 and promote myogenesis, Trf3 is turned
on after teratoma formation and Taf3 mRNA is still expressed
at modest levels in TAF3 K/D teratomas (3-fold less than
control; Figure S5D), This presents the intriguing possibility
that enhanced early mesoderm differentiation might override
the later negative effects of TAF3 K/D on myogenesis.724 Cell 146, 720–731, September 2, 2011 ª2011 Elsevier Inc.TAF3 K/D Blocks Both Primitive and Definitive
Endoderm Differentiation
Our results strongly suggest that TAF3 is required for the expres-
sion of endodermal genes (Figure 3A and Figures 4A and 4B) but
do not clearly distinguish between the primitive and definitive
endoderm lineages. As these have very similar molecular signa-
tures (Grapin-Botton and Constam, 2007), we sought to exclude
the possibility that downregulation of one could mask upregula-
tion of the other. Specifically, although defects in expression
of the well-characterized primitive endoderm-specific genes
(Sox7, Lamb1, Col4a2, and Sparc) (Figure 4A) provide strong
evidence that specification of primitive endoderm was impeded,
most definitive endoderm markers (Foxa2, Sox17, and Hnf4a)
are pan-endodermal and require additional context. We
therefore directed control and TAF3 K/D cells toward definitive
endoderm using Activin A (Gadue et al., 2006) and analyzed
the resulting definitive endoderm (CXCR+c-Kit+) and mesoderm
Figure 5. TAF3 Is Required for Efficient ES Cell Differentiation into
Definitive Endoderm
(A) Flow cytometric analysis of definitive endoderm (CXCR4+c-kit+) and
mesoderm (CXCR4+Flk-1+) cells after the directed in vitro differentiation.
Experiments were conducted with or without Activin A.
(B)qRT-PCR toexamine the relativeexpressionofendoderm(Sox17,Foxa2) and
mesoderm (Mesp1) markers in Activin A treated samples. See also Figure S5.(CXCR4+Flk-1+) cell populations by flow cytometry (Figure 5A).
Definitive endoderm differentiation was much less efficient in
the TAF3 K/D samples (16%–19%) than control samples
(43%–45%). By contrast, mesoderm differentiation was
enhanced from 22% in control samples to 39%–46% in
TAF3 K/D samples. Since both definitive endoderm and meso-
derm are derived from a common precursor in cell culture, mes-
endoderm (Tada et al., 2005), it is likely that during normal devel-
opment TAF3 favors the expression of endodermal genes. This
hypothesis is further supported by our qRT-PCR results
(Figure 5B).
As an additional independent test of the role of TAF3 in defin-
itive endoderm differentiation, we took advantage of human ES
cells that were programmed to form definitive endoderm
(Sox17 O/E lines; (Seguin et al., 2008). Orthologous genes that
increase during differentiation to definitive endoderm in human
ES cells were downregulated following TAF3 K/D in mouse ES
cells and vice versa (Figure 4C). Thus, multiple lines of evidence
show that TAF3 is required for both primitive and definitive endo-
derm development.TAF3 as a TFIID Subunit Targets Core Promoters
in ES Cells
Given the wide-ranging consequences of TAF3 depletion we
sought to identify direct targets of TAF3 regulation. Are the
high levels of TAF3 in ES cells mainly a component of TFIID or
are there other TAF3 containing complexes in play akin to the
situation found during myotube formation? Can we survey the
diversity of genes bound by TAF3 and perhaps discern some
differential function associated with activated versus repressed
genes? To address these questions we performed ChIP-seq
experiments on TAF3, two canonical TFIID subunits (TBP,
TAF1) and Pol II in mouse ES cells. TAF3 was robustly detected
at 80% of promoters (Figure 6A and Figure S6A; p = 0 by permu-
tation) and its enrichment at promoters was strongly correlated
with that of TAF1 and TBP (Figure 6C). TAF3 has been shown
to anchor TFIID to H3K4me3 in human cell lines (Vermeulen
et al., 2007) and our data verify that this relationship is likely to
persist in mouse ES cells: Enrichments of TAF1, TBP, and
TAF3 all correlate strongly with H3K4me3 levels (Figure 6C).
Together with previous evidence of copurification (Gangloff
et al., 2001), these data leave little doubt that TAF3 binds core
promoters in ES cells as a component of TFIID.
TAF3 binding at promoters was also positively correlated with
Pol II binding (R = 0.78, p < 1E-10; Figure 6C; Figure S6B) and the
level of expression as assayed by mRNA-seq (R = 0.51, p <
1E-10). Surprisingly however, we were unable to detect signifi-
cant differences in TAF3 enrichment between promoters of
TAF3 dependent genes and other genes (Figure S6G). Similarly,
a simple linear model of expression as a function of TAF3, TAF1,
and TBP promoter binding identified a large shared contribution
(presumably corresponding to TFIID), but no residual relation-
ship between promoter-bound TAF3 and expression changes
following TAF3 K/D (data not shown). Thus, although TAF3 is re-
cruited to core promoters in ES cells and contributes to gene
expression via TFIID, this function of TAF3 does not appear to
account for the defects in lineage-specific expression observed
upon depletion of TAF3 from ES cells.
Binding of TAF3 Is Correlated with Binding of CTCF
and Cohesin
Although the vast majority of regions enriched for TAF1, TBP or
Pol II were also enriched for TAF3, the opposite was not true. At
a false discovery rate of 1% our ChIP-seq data indicated that
19K (of 38K total) regions enriched for TAF3 binding were not en-
riched for any of TAF1, TBP or Pol II (range 12–19K; Figure 6A,
solid box and Figure S6C). These regions were generally further
from core promoters (Figure S6D) and less enriched (Figure S6E)
than TFIID-associated regions but often overlapped with regions
enriched for other factors active in ES cells (Figure S6F). For
example, the number of CTCF peaks coincident with TFIID-inde-
pendent TAF3 peaks was ten times that expected by chance. To
get a more quantitative understanding of TAF3 binding in ES
cells, we computed correlations among 17 factors at 125K loca-
tions across the genome (see Experimental Procedures). These
correlations correctly reconstructed the known relationships
among all 17 factors such as the concerted binding of TFIID
components to promoters and the association between TFIID/
Pol II and H3K4me3 in ES cells (Figure 6C). Notably however,Cell 146, 720–731, September 2, 2011 ª2011 Elsevier Inc. 725
Figure 6. TAF3 Binds Core Promoters with TFIID and Distal Sites in a TFIID-Independent Manner
(A) Read accumulation for six ChIP-seq datasets (TAF3, TBP, Pol II, H3K4me3, CTCF, and Oct4) at the Gata4 locus. Vertical axis was from 3–50 reads for all
factors. TAF3 dependent expression changes were plotted below genes as for Figure 4. Peaks referenced in the text were boxed and numbered as in panels
(D)–(F). Active promoters were denoted with dashed boxes.
(B) As for (A) at the Lefty1 locus.
(C) Binding correlations (Spearman coefficient) between all pairs of factors considered in this study based on enrichment values calculated using the MACS
model at 125 K genomic loci. Negative correlations were set to zero for display.
(D) Clustering of TAF3 bound regions into four classes using the first three principal components of binding variation computed from all factors in (C).
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we also identified a striking correlation between the binding of
TAF3 and CTCF that is not shared by any other member of TFIID
or Pol II. A similar relationship was observed for cohesin (Smc1A,
Smc3) and both relationships were found to be more robust
when located distal to the core promoter. The observation that
high levels of TAF3 at promoter distal sites are often accompa-
nied by high levels of CTCF and cohesin while low levels of
TAF3 signal low levels of CTCF and cohesin suggests that these
molecules operate together at these promoter distal sites to
perform a linked function. Moreover, as there was no correlation
between binding of TAF1, TBP, or Pol II with CTCF, this TAF3
activity does not appear to depend on TFIID (Figure 6C). Exam-
ples of regions enriched for TAF3 and CTCF are shown in
Figure 6B.
Regions Enriched for TAF3, CTCF, and Cohesin
Distinguish TAF3-Activated from TAF3-Repressed
Genes
Given the existence of distinct classes of TAF3 binding, one
plausible explanation for the opposing effects of TAF3 depletion
on neuroectodermal and endodermal genes is that they are
subject to different types of TAF3 regulation. To discriminate
regions bound by TAF3 in the context of different partners, we
performed principal components analysis on our dataset and
clustered regions significantly enriched for TAF3 into four
classes (Figure 6D; see Experimental Procedures). This proce-
dure groups together regions that have similar enrichment
profiles (Figure 6E) across all 17 factors and histone modifica-
tions examined in Figure 6C. Briefly, as well as TAF3, class 1
regions are enriched for TFIID, Pol II and H3K4me3. Their prox-
imity to the TSS of known genes confirms that they are predom-
inantly TFIID-bound core promoters (Figure 6E). By contrast,
Class 2 regions have low levels of TFIID and H3K4me3 but are
enriched for Oct4/Nanog/Sox2 and mediator components.
They are considered further in the Discussion. Class 3 regions
are specifically enriched for TAF3, CTCF, and cohesin subunits,
and correspond to the novel function proposed above. Finally,
class 4 regions are not enriched for any of the factors we consid-
ered besides TAF3 (Figure 6A).
We testedwhether particular TAF3 binding classes were asso-
ciated with TAF3-dependent genes by comparing the density of
each bound region type (within 100Kb of the gene) between
TAF3-dependent genes and sets of matched control genes
(see Experimental Procedures). Genes whose expression was
TAF3-dependent in ES cells exhibited genome-wide associa-
tions with TAF3 binding classes that were not observed among
control genes (Figure 6F). First, both up- and downregulated
genes were enriched for at least one class of TAF3 bound region
compared to controls, suggesting that TAF3 may directly regu-
late both sets of genes. Second, up- and downregulated genes
exhibited radically different associations with TAF3 bound
regions. Most strikingly, whereas genes downregulated upon(E) Summary statistics for the four TAF3 binding classes in (D). All values except th
class. Enrichment was calculated as for (C).
(F) Z-score association between TAF3 binding classes from (D) and genes whose e
underlined; Z-score between ±1 (p value > 0.6); Z-scores > 2 (p value < 0.05); Z-s
calculation. For related details see also Figure S6.TAF3 K/D were surrounded by more regions enriched for
TAF3, CTCF and cohesin (Class 3 regions; Figures 6D–6F)
than expected by chance, no such association was seen for
genes upregulated upon TAF3 K/D (Figure 6F). The simplest
interpretation of these data is that class 3 regions are required
by certain genes for efficient expression and are enriched in
the vicinity of these genes. Depletion of TAF3 interferes with
this function. By contrast, genes that are upregulated after
TAF3 K/D rely on other mechanisms to achieve high levels of
expression. Indeed, our data suggest that activation by Sox2,
Oct4, and Nanog may comprise such an alternative mechanism
that can apparently be opposed by TAF3 (Figure 6F). Our data
support two other observations. First, regions bound by TAF3
only (Class 4 regions; Figures 6 D–6F) are also associated with
downregulated genes upon TAF3 K/D. This suggests that TAF3
may also contribute to lineage commitment at distal sites by
mechanisms independent of CTCF/cohesin. Second, TAF3
binding in the context of TFIID (Class 1 regions; Figures 6
D–6F) is associated neither with up- nor downregulated genes.
This is confirms our previous observations (Figure S6G) and is
consistent with the critical role played by TFIID at the basal
promoters of many genes.
CTCF Directly Interacts with and Recruits TAF3
to Promoter Distal Sites
The strongly correlated binding of CTCF and TAF3 to promoter
distal sites (Figure 6E) suggested that these two proteins may
be tightly associated perhaps even forming a protein complex.
Consistent with this hypothesis, TAF3 and CTCF were coeluted
when ES cell nuclear extracts were chromatographed on
a Superose 6 column (Figure S1B). Importantly, CTCF but not
cohesin (Smc1a and Smc3) or mediator subunit (Med12) was
selectively enriched by TAF3 immunoprecipitation (Figure 7A)
and the interaction between TAF3 and CTCF appears to be
direct and independent of DNA (Figure 7A; lane 4). Coimmuno-
precipitations using 293T cells expressing full length or trun-
cated Flag-HA-tagged TAF3 and CTCF proteins confirmed that
TAF3 directly interacts with CTCF through its vertebrate-specific
region (501–730aa) without assistance of the Histone Fold
(1–79aa) or the PHD finger (869–914aa) (Figures 7B and 7C).
To test the order of the recruitment between TAF3 and CTCF,
we examined the occupancy of CTCF and TAF3 at distinct sets
of genomic loci in control, TAF3 K/D and CTCF K/D cells. We
found that CTCF continues to bind its target sites in the absence
of TAF3 (Figure S7A) whereas CTCF is required for efficient
recruitment of TAF3 to distal (TAF3/CTCF) sites but not required
for TAF3 occupancy at core promoters (Figure 7D). These find-
ings further validate the functional relationship between TAF3
and CTCF. Moreover, they confirm that TAF3 localization to
CTCF-bound sites (Class 3 in Figure 6) is mechanistically distinct
from TAF3 localization to TFIID-bound regions (Class 1 in Fig-
ure 6), corroborating our computational inference of distincte number of regions in each class (first column) are median values for the whole
xpressionwas significantly affected by TAF3 depletion. Significant valueswere
cores > 3 (p value < 0.001). See Experimental Procedures for details of Z-score
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Figure 7. TAF3 Interacts with CTCF and Mediates DNA Looping
(A) Western blots to examine the relative enrichment of cohesin (Smc1a and Smc3), mediator subunit (med12) and CTCF by TAF3 immunoprecipitation using
ES cell nuclear extracts. B + E, Benzonase and Ethidium bromide treatment that eliminates DNA-mediated interactions.
(B and C) Mapping the CTCF-interacting domain of TAF3. Flag-HA tagged TAF3, RFP or truncated TAF3 proteins were overexpressed in 293T cells with CTCF
and were then purified with anti-Flag resin. TAF3 and CTCF enrichments were analyzed by western blots. (C) Coomassie Staining of the purified Flag-HA-
TAF3(501-730aa)/CTCF complex.
(D) ChIP analysis to examine the relative TAF3 enrichments at 6 core promoters bound by TAF3 and 11 distal sites bound by TAF3/CTCF in control and CTCF K/D
cells.
(E) 3C experiments to assess long-range interactions between the distal TAF3/CTCF/cohesin site and regions around the core promoter ofMapk3 in control (blue)
and TAF3 K/D (red) cells.:, anchor point.
(F) Western blots to examine TAF3 and CTCF protein levels in control, TAF3 K/D (shRNA A), CTCF K/D (shRNA #1) and TAF3 & CTCF K/D cells (72 hr post-
infection).
(G) qRT-PCR analysis to measure Mapk3 expression in control, TAF3 K/D, CTCF K/D and TAF3 & CTCF K/D cells.
(H) TAF3 interacts with CTCF and mediates regulatory DNA looping to specify endoderm differentiation. See also Figure S7.
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TAF3-binding categories. These observations together provide
strong evidence for an unexpected promoter distal coactivator
mechanism involving TAF3 in association with CTCF.
TAF3 Mediates DNA Looping between the Promoter
Distal Sites and Core Promoters Occupied
by TAF3/CTCF/Cohesin
The over-representation of TAF3/CTCF/cohesin bound regions
associated with TAF3-activated genes suggests that TAF3might
provide a novel function at these locations to activate gene tran-
scription possibly by facilitating long-distance DNA looping. To
address this possibility, we focused on two TAF3-activated
genes,Mapk3 and Psmd1 (Table S1), which could be confidently
associated with specific TAF3/CTCF/cohesin sites (most are
10 s of kbs from the nearest TSS’s and thus cannot be unambig-
uously assigned to a specific target gene). Each of these genes is
located at 5 kb downstream of a TAF3/CTCF/cohesin bound
region with no other TSS nearby. Chromatin Conformation
Capture (3C) experiments were performed to scan the interac-
tion frequency between the promoter distal site and regions
within the gene locus. In each case, DNA looping between the
distal TAF3/CTCF/cohesin site and the core promoter was
observed and, notably, TAF3 is required for efficient DNA looping
(Figure 7E and Figure S7B). These findings strongly support
a molecular mechanism in which TAF3/CTCF mediates long-
range chromatin transactions that likely regulate proper tran-
scription activation (Figure 7H). Consistent with this model,
shRNA mediated depletion of CTCF also reduced expression
of these genes and the simultaneous K/D of TAF3 and CTCF
did so more effectively (Figures 7F and 7G and Figure S7C).
Since activation of Ras/Erk/Mapk is sufficient to induce primitive
endoderm differentiation (Li et al., 2010; Verheijen et al., 1999),
the downregulation of Mapk3 is a likely contributor to the endo-
derm defects we observed in TAF3 K/D samples (Figure 4A).
Together, these results strongly suggest that TAF3 and CTCF
act together at a subset of CTCF sites to perform a linked func-
tion important for specifying endoderm lineages (Figure 7H). To
further verify this model, CTCF K/D cells were induced to form
EBs. As expected, we observed significantly compromised
endoderm differentiation as demonstrated by loss of marker
(Gata4, Afp, and Apoa1) expression (Figures S7D and S7E).
Interestingly, these defects were less dramatic than those seen
upon TAF3 depletion, indicating that other CTCF-independent
functions mediated by TAF3 might also play a role. One possi-
bility is that the Class 4 binding regions (Figures 6D–6E) that
are also associated with TAF3-activated genes (Figure 6F)
contribute to endodermal gene expression. TAF3may also regu-
late lineage commitment via one of its core promoter functions
such as H3K4me3 binding.
DISCUSSION
TAF3 Regulates Lineage Commitment
Anotable feature of ourmRNA-seq data is that, although a similar
number of genes was affected by TAF3 K/D at each time point,
many more lineage-specific genes were over-represented at
later time points (Table S1 and Table S2). Thus, an interesting
question is what underlies the progressive bias toward lineage-specific genes. The most parsimonious explanation is that
TAF3 K/D first induces a broad effect on gene expression.
However, some of the genes that TAF3 regulates are likely crit-
ical for appropriate lineage specification. The altered expression
of these genes upon TAF3 depletion (1) would directly limit the
differentiation potential of cells, or (2) would lead to altered
cellular responses to environmental and physiological signaling
events. Consistent with mechanism 1, key developmental regu-
lators of neuroectoderm and endoderm became profoundly
affected by depletion of TAF3 in ES cells. Indeed, our findings
suggest that TAF3 directly influences the balance between neu-
roectoderm and endoderm differentiation of ES cells at the tran-
scriptional level. This initial misregulation may in turn trigger
a temporal cascade of changes that disrupt lineage-specific
programs of gene expression (Figure 4A and S4A). Several lines
of evidence suggest that TAF3 K/D may also indirectly affect
mesoderm differentiation at later times by disrupting some key
signaling pathways (mechanism 2). For example, many genes
involved in mesoderm formation (T, Nodal, Gsc, Wnt3, Wnta,
Foxh1, and Fgf8) were not significantly altered until EB day 3 or
day 6 (Figure 4A), more consistent with an indirect regulation
by TAF3. Significantly, some core mesoderm patterning
programs malfunctioned and became unresponsive to the over-
expression of nodal antagonist Cer1/Lefty1 (Figure 4A), that nor-
mally represses mesoderm formation (Tam and Loebel, 2007).
Likewise, TGF-b signaling became deregulated upon TAF3
depletion. Specifically, when cells lacking TAF3 were exposed
to activin A (TGF-b activator) concentrations that would normally
induce definitive endoderm differentiation, TAF3 K/D cells
instead differentiated more into mesoderm (Figure 5). Taken
together, these results are most consistent with TAF3 mediating
two distinct mechanisms that regulate proper lineage
specification.
Multifaceted Roles of TAF3 in Transcriptional
Regulation
Given the well-established role of TAF3 in TFIID, it’s quite
surprising that, with the exception of the modest downregulation
of some housekeeping genes (Table S1 and Table S2), we were
unable to detect an obvious association between levels of TAF3
at proximal core promoters (i.e., in TFIID) and changes in gene
expression following TAF3 K/D. One possible explanation is
that for the large class of genes where TAF3 functions as part
of the prototypic TFIID complex the residual low levels of TAF3
after K/Dmimic the low levels typically seen in differentiated cells
(i.e., muscle) and are sufficient to maintain TFIID function in ES
cells. In such a model, the very high levels of TAF3 seen in ES
cells may engage in additional ES cell-specific functions.
Intriguingly, the striking enrichment of TAF3 at regions bound
by CTCF and cohesin presents a likely candidate for an ES cell-
specific function. Although the data shown here do not exclude
the possibility that TAF3 and CTCF also bind together in differen-
tiated cell types, they strongly suggest that TFIID is absent from
the majority of these regions in ES cells (Figures 6B and 6C).
Indeed, conventional ‘‘peak-calling’’ methods (Zhang et al.,
2008) determined that 5463 regions were enriched for TAF3,
CTCF and some combination of cohesin and mediator subunits
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enriched for TBP but not TAF3. By contrast, essentially every
region bound by TAF1 and Pol II is enriched for both TAF3
(98%) and TBP (94%). Even more importantly, these regions
are over-represented around TAF3-activated genes (Figure 6F),
thus establishing a potential mechanism for the differential regu-
lation of genes from different lineages.
CTCF has been implicated in multiple regulatory functions,
including transcriptional activation/repression, insulator activity
and imprinting (Phillips and Corces, 2009). The molecular basis
of these diverse activities remains unclear. Here we show that
by interacting with CTCF, TAF3 can directly mediate linkages
between distal TAF3/CTCF/cohesin bound regions and proximal
core promoters thus providing another means to influence tran-
scription activation at target genes (Figure 7H). Our genome-
wide correlation analysis (Figure 6F) suggests that this mecha-
nism likely governs the proper transcription of many genes.
However, it’s worth noting that our data do not exclude the
possibility that TAF3 could also perform core promoter indepen-
dent functions with CTCF at those locations.
In addition to regions that are bound by TAF3 in the context of
TFIID and those that are bound in the context of CTCF/cohesin,
our data suggest that twoothermodesof TAF3bindingmayexist.
Specifically, we observe a class of sites that appear to be en-
riched for TAF3only (Figure 6A) and another class that is enriched
for Oct4/Nanog/Sox2 as well as mediator subunits (Figure 6B).
Although it has been previously shown that not all binding is func-
tionally significant (Li et al., 2008; MacArthur et al., 2009), these
cases are interesting as they exhibit biased representation with
respect to TAF3-dependent genes. Notably, the class 2 binding
regions are enriched around upregulated genes upon TAF3
depletion (Figure 6F), consistent with a mechanism of transcrip-
tion repression by TAF3 in association with Oct4/Nanog/Sox2.
If indeed TAF3 is involved with new functions at these regions,
it could represent an interesting point of convergence between
pathways responsible for self-renewal and pluripotency.
The present work demonstrates a novel ES cell-specific role of
TAF3 in maintaining pluripotency. In conjunction with our
previous work on TAF3 and other examples such as TAF4b
(Goodrich and Tjian, 2010), these studies collectively reinforce
cell-type-specific regulatory functions of components of core
promoter complexes as a general paradigm. Indeed, it now
seems likely that this idea may have very wide applicability.
For example, during the course of demonstrating a specialized
role for TAF3 in myotubes, we found that mediator components
were specifically downregulated in these cells (Deato et al.,
2008). This parallels independent work showing that multiple
mediator subunits are required along with cohesin for Oct4
expression and ES cell self-renewal (Kagey et al., 2010). Given
these commonalities (especially the link to cohesin), it was
striking to find a negligible self-renewal phenotype in TAF3 K/D
cells (Figure 2). Is it possible that these core promoter factors
have been charged with independently guaranteeing the two
defining characteristics of stem cells? If this hypothesis survives
additional testing it may suggest that along with site-specific
transcription factors and chromatin modifiers (Jaenisch and
Young, 2008), core promoter complexes and their associated
functions comprise another important layer of transcriptional
regulation for safeguarding the integrity of the stem cell state.730 Cell 146, 720–731, September 2, 2011 ª2011 Elsevier Inc.EXPERIMENTAL PROCEDURES
ES Cell Maintenance
Mouse D3 (ATCC) and 46C ES cells were cultured on 0.1% gelatin coated
plates in the absence of feeder cells. The ES cell medium was prepared by
supplementing knockout DMEM (Invitrogen) with 15% FBS, 1 mM glutamax,
0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 0.1 mM 2-mercap-
toethanol, and 1000 units of LIF (Millipore). Mouse R1 (ATCC) was maintained
in the same medium with a feeder layer of irradiated MEFs (Passage 3).
Validation of mRNA-Seq and ChIP-Seq Data by Q-PCR
Relative mRNA abundance of 40 genes that showed differential expression at
EB day 6 (shRNA A) were confirmed with qRT-PCR by comparing shRNA B
treated samples with controls (Figures S4B and S4C). Enrichment of distinct
sets of factors as indicated at 21 genomic regions was validated by ChIP-
qPCR using a rabbit antibody and a guinea pig antibody against TAF3 (Fig-
ure S6H). The primer information for data validation is in Table S3. ChIP-seq
and mRNA-seq datasets have been archived in GEO with SuperSeries acces-
sion GSE30959.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and three tables and can be found with this article online at doi:10.
1016/j.cell.2011.08.005.
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